Swami Aseemanand, associates acquitted in 2007 Makkah Masjid terror attack case

coastaldigest.com web desk
April 16, 2018

Hyderabad, Apr 16: A special National Investigation Agency (NIA) court on Monday acquitted five prominent accused in 11-year-old Hyderabad Makkah Masjid blast case, including Swami Aseemanand.

The blast, using an improvised explosive device, killed nine persons inside the masjid near the historic Charminar of Old City.

The NIA took over the case from the Central Bureau of Investigation (CBI) in 2011. At the time, 10 people were named as accused by the central probing agency.

Accused Sunil Joshi of Madhya Pradesh, a former Rashtriya Swayamsevak Sangh (RSS) pracharak, was murdered when the case was investigated. It was believed that the intention behind the murder to cover up the case and destroy evidence.

Two other accused, former RSS pracharak Sandeep V. Dange and RSS activist and electrician Ramchandra Kalsangra, also from Madhya Pradesh, have been eluding the investigators.

Investigations against two others from the same State, Tejram Parmar and Amith Chowhan, are continuing.

Investigators framed charges against RSS pracharak Devendra Guptha of Rajasthan; RSS activist and property dealer, Lokesh Sharma of MP; 'godman' Nabakumar Sarkar alias Swamy Aseemanand of Gujarat, private employee Bharat Mohanlal Rateshwar of Gujarat and farmer Rajender Chowdary of Madhya Ptadesh.

Also Read: Makkah Masjid blast: Acquittal of accused a matter of shame for the country, says witness

Comments

Kalimama
 - 
Tuesday, 17 Apr 2018

NIA is the biggest gaddar orginazition of our country they will dance as per the master..

Well Wisher
 - 
Monday, 16 Apr 2018

Hahahah, 

Another comedy on our indian law. Weak law has been tightened. 

sorry to hear this.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 3,2020

Bengaluru, May 3: Renowned Kannada poet KS Nissar Ahmed passed away on May 3.

Winner of several awards including Karnataka Sahitya Akademi Award for Poetry, Rajyotsava Award, Padma Shri among others, Ahmed died at the age of 84

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 26,2020

Kochi, Feb 26: Kerala High Court on Wednesday imposed a ban on strikes in schools and colleges that impact the functioning of the campuses.

''The functioning of campuses should not be hampered by the strikes. The colleges are for study, not for strikes. There should not be any march or gherao on campuses. Do not incite anyone for a strike," a bench of Justice PB Suresh Kumar said in its order.

"The order applies to schools and colleges. Do not harm the rights of others. The college can be a venue for peaceful discussions or thoughts. If actions are contrary to the orders of the court, the authorities can take action. They can call the police and restore peace," the order reads.

The Kerala High Court issued the order while hearing a petition filed by 20 educational institutions against campus politics.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.